EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The role of myeloid-derived immunosuppressive cells in cardiovascular disease

Qingmei Li, Aihua Mei, Hang Qian, Xinwen Min, Handong Yang, Jixin Zhong, Chunlei Li, Hao Xu, Jun Chen

International Immunopharmacology · 2023-04 · 117 · 109955

DOI: 10.1016/j.intimp.2023.109955 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2023-04. Verfasst von Qingmei Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Sinopharm Dongfeng General Hospital (Hubei Clinical Research Center of Hypertension), Hubei University of Medicine, Hubei Key Laboratory of Wudang Lo…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Myeloid-Derived Suppressor Cells, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 109 Literaturangaben. Gefördert von: Hubei Key Laboratory of Wudang Local Chinese Medicine Research, National Natural Science Foundation of China, Natural Science Foundation of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myeloid-derived suppressor cells (MDSCs) are a heterogeneous cell population found in the bone marrow, peripheral blood, and tumor tissue. Their role is mainly to inhibit the monitoring function of innate and adaptive immune cells, which leads to the escape of tumor cells and promotes tumor development and metastasis. Moreover, recent studies have found that MDSCs are therapeutic in several autoimmune disorders due to their strong immunosuppressive ability. Additionally, studies have found that MDSCs have an important role in the formation and progression of other cardiovascular diseases, such as atherosclerosis, acute coronary syndrome, and hypertension. In this review, we will discuss the role of MDSCs in the pathogenesis and treatment of cardiovascular disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesMyeloid-Derived Suppressor CellsNeoplasmsHumansMyeloid CellsImmunosuppressive Agents

Stichwörter der Autor:innen

Acute coronary syndromeAtherosclerosisHeart failureHypertensionMyeloid immunosuppressive cells

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Sinopharm Dongfeng General Hospital (Hubei Clinical Research Center of Hypertension), Hubei University of Medicine, Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine), Shiyan,…
  • Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China.

Förderung

  • Hubei Key Laboratory of Wudang Local Chinese Medicine Research
  • National Natural Science Foundation of China
  • Natural Science Foundation of Hubei Province
  • Natural Science Foundation of Jiangsu Province
  • Hubei University of Medicine

Zitieren

APA

Li, Q., Mei, A., Qian, H., Min, X., Yang, H., Zhong, J., Li, C., Xu, H., & Chen, J. (2023). The role of myeloid-derived immunosuppressive cells in cardiovascular disease. International Immunopharmacology, 117, 109955. https://doi.org/10.1016/j.intimp.2023.109955

Vancouver

Li Q, Mei A, Qian H, Min X, Yang H, Zhong J, et al. The role of myeloid-derived immunosuppressive cells in cardiovascular disease. International Immunopharmacology. 2023;117:109955. doi:10.1016/j.intimp.2023.109955

BibTeX
@article{Li2023,
  author = {Li, Qingmei and Mei, Aihua and Qian, Hang and Min, Xinwen and Yang, Handong and Zhong, Jixin and Li, Chunlei and Xu, Hao and Chen, Jun},
  title = {The role of myeloid-derived immunosuppressive cells in cardiovascular disease},
  journal = {International Immunopharmacology},
  year = {2023},
  volume = {117},
  pages = {109955},
  doi = {10.1016/j.intimp.2023.109955}
}
Kostenlos starten →